Quantification of PET Amyloid and Tau Ligand [F-18]FDDNP in early Alzheimer disease

被引：0
|
作者：
Tauber, C. [1 ]
Vercouillie, J. [1 ]
Kepe, V. [2 ]
Beaufils, E. [3 ]
Venel, Y. [3 ]
Baulieu, J. [3 ]
Gendre, D. [4 ]
Barrio, J. [2 ]
Cottier, J. [3 ]
Mondon, K. [3 ]
Hommet, C. [3 ]
Camus, V. [3 ]
Guilloteau, D. [5 ]
机构：
[1] Univ Tours, UMRS INSERM U930, CNRS ERL3106, Tours, France
[2] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, D Geffen Sch Med, Los Angeles, CA USA
[3] Hop Bretonneau, CHRU Tours, Tours, France
[4] Ctr Invest Clin CIC U202, Tours, France
[5] CHRU Tours, INSERM U930, CIC IT 806, Tours, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [31] Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET
    Hiroshi Matsuda
    Yoko Shigemoto
    Noriko Sato
    Japanese Journal of Radiology, 2019, 37 : 735 - 749
  • [32] Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET
    Matsuda, Hiroshi
    Shigemoto, Yoko
    Sato, Noriko
    JAPANESE JOURNAL OF RADIOLOGY, 2019, 37 (11) : 735 - 749
  • [33] CLINICAL AND [F-18] DOPA PET FINDINGS IN EARLY PARKINSONS-DISEASE
    MORRISH, PK
    SAWLE, GV
    BROOKS, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (06): : 597 - 600
  • [34] LABELING OF A SEROTONINERGIC LIGAND WITH F-18 - [F-18] SETOPERONE
    CROUZEL, C
    VENET, M
    IRIE, T
    SANZ, G
    BOULLAIS, C
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (04): : 403 - 414
  • [35] Dynamic Amyloid PET: Relationships to Tau PET and Cognition in Alzheimer's Disease
    Raman, Fabio
    McConathy, Jonathan
    Benzinger, Tammie
    Flores, Shaney
    Ponisio, Maria
    Chen, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [36] Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
    Aschenbrenner, Andrew J.
    Gordon, Brian A.
    Benzinger, Tammie L. S.
    Morris, John C.
    Hassenstab, Jason J.
    NEUROLOGY, 2018, 91 (09) : E859 - E866
  • [37] 18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification
    Alongi, Pierpaolo
    Sardina, Davide Stefano
    Coppola, Rosalia
    Scalisi, Salvatore
    Puglisi, Valentina
    Arnone, Annachiara
    Di Raimondo, Giorgio
    Munerati, Elisabetta
    Alaimo, Valerio
    Midiri, Federico
    Russo, Giorgio
    Stefano, Alessandro
    Giugno, Rosalba
    Piccoli, Tommaso
    Midiri, Massimo
    Grimaldi, Luigi M. E.
    JOURNAL OF NEUROIMAGING, 2019, 29 (03) : 383 - 393
  • [38] Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET
    Jeong, Young Jin
    Yoon, Hyun Jin
    Kang, Do-Young
    MEDICINE, 2017, 96 (48)
  • [39] In vivo brain imaging of tau aggregation in frontal temporal dementia using [F-18]FDDNP positron emission tomography
    Small, GW
    Kepe, V
    Huang, SC
    Wu, HM
    Siddarth, P
    Ercoli, L
    Miller, K
    Lavretsky, H
    Wright, BC
    Shoghi-Jadid, K
    Satyamurthy, N
    Phelps, ME
    Barrio, JR
    NEUROBIOLOGY OF AGING, 2004, 25 : S288 - S289
  • [40] Preliminary quantitative evaluation of 18F-FDDNP PET/CT in Alzheimer's disease, using different regions of reference
    Michaud, L.
    Venel, Y.
    Le Borgne, A.
    Santiago-Ribeiro, M. -J
    Guilloteau, D.
    Tauber, C.
    Baulieu, J. -L.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2013, 37 (12): : 578 - 585
12345